NO165400C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.

Info

Publication number
NO165400C
NO165400C NO850010A NO850010A NO165400C NO 165400 C NO165400 C NO 165400C NO 850010 A NO850010 A NO 850010A NO 850010 A NO850010 A NO 850010A NO 165400 C NO165400 C NO 165400C
Authority
NO
Norway
Prior art keywords
preparation
therapeutic active
analogy procedure
cefem compounds
cefem
Prior art date
Application number
NO850010A
Other languages
English (en)
Norwegian (no)
Other versions
NO850010L (no
NO165400B (no
Inventor
Gordon Gad Weingarten
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO850010L publication Critical patent/NO850010L/no
Publication of NO165400B publication Critical patent/NO165400B/no
Publication of NO165400C publication Critical patent/NO165400C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • C07C59/315—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups containing halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO850010A 1984-01-03 1985-01-02 Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser. NO165400C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848400024A GB8400024D0 (en) 1984-01-03 1984-01-03 Cephalosporin antibiotics

Publications (3)

Publication Number Publication Date
NO850010L NO850010L (no) 1985-07-04
NO165400B NO165400B (no) 1990-10-29
NO165400C true NO165400C (no) 1991-02-06

Family

ID=10554497

Family Applications (1)

Application Number Title Priority Date Filing Date
NO850010A NO165400C (no) 1984-01-03 1985-01-02 Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.

Country Status (28)

Country Link
US (1) US4602012A (sv)
JP (1) JPH0791305B2 (sv)
KR (1) KR920001770B1 (sv)
AT (1) AT392279B (sv)
AU (1) AU578441B2 (sv)
BE (1) BE901436A (sv)
CA (1) CA1265512A (sv)
CH (1) CH666274A5 (sv)
DE (1) DE3500090A1 (sv)
DK (1) DK1585A (sv)
ES (2) ES8703884A1 (sv)
FI (1) FI83082C (sv)
FR (1) FR2557571B1 (sv)
GB (2) GB8400024D0 (sv)
GR (1) GR850007B (sv)
HK (1) HK105890A (sv)
HU (1) HU193076B (sv)
IL (1) IL73989A (sv)
IT (1) IT1178349B (sv)
LU (1) LU85719A1 (sv)
NL (1) NL8403974A (sv)
NO (1) NO165400C (sv)
NZ (1) NZ210725A (sv)
PH (1) PH22630A (sv)
PT (1) PT79787B (sv)
SE (2) SE8500011L (sv)
SG (1) SG81390G (sv)
ZA (1) ZA8545B (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8320521D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
DE3804841A1 (de) * 1988-02-17 1989-08-31 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
GB8810396D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
GB8810395D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
GB8810393D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
GB8810392D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
GB8810394D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
US5063224A (en) * 1990-07-09 1991-11-05 Eli Lilly And Company R-cefuroxime axetil
EP0504107B1 (de) * 1991-03-11 1994-12-07 Säurefabrik Schweizerhall Verfahren zur Herstellung von chlorierten Carbonsäureestern
EP0508943B1 (de) * 1991-03-11 1994-12-14 Säurefabrik Schweizerhall Verfahren zur Herstellung von halogenierten Carbonsäureestern
GB9405856D0 (en) * 1994-03-24 1994-05-11 Smithkline Beecham Plc Pharmaceutical formulation
JP2001131071A (ja) * 1999-10-29 2001-05-15 Meiji Seika Kaisha Ltd 非晶質および非晶質を含有する医薬組成物
PT1342470E (pt) * 2002-03-04 2007-11-13 Orbus Pharma Inc ''composições de cefuroxima axetil de libertação rápida''
WO2008155615A2 (en) * 2007-06-18 2008-12-24 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of cephalosporin antibiotic

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1453049A (en) * 1973-08-21 1976-10-20 Glaxo Lab Ltd Cephalosporing antibiotics
GB1426717A (en) * 1972-03-13 1976-03-03 Astra Laekemedel Ab Penicillins
GB1425933A (en) * 1972-03-13 1976-02-25 Astra Laekemedel Ab Cephalosporins
CA1093549A (en) * 1976-02-16 1981-01-13 Michael Gregson Cephalosporin antibiotics
GB1571683A (en) * 1976-02-16 1980-07-16 Glaxo Operations Ltd Ester derivatives of cefuroxime
GB1572993A (en) * 1976-02-16 1980-08-13 Glaxo Operations Ltd Ester derivatives of cefuroxime
CA1094545A (en) * 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
GB1598568A (en) * 1977-04-19 1981-09-23 Glaxo Lab Ltd Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid
FR2476087A1 (fr) * 1980-02-18 1981-08-21 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
IT1210868B (it) * 1982-04-01 1989-09-29 Opos Biochimica Srl Derivati della cefuroxima attivi per via orale procedimenti per laloro preparazione e relative composizioni farmaceutuche.
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
GB8320520D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8320521D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process

Also Published As

Publication number Publication date
ES8705891A1 (es) 1987-05-16
FI83082C (sv) 1991-05-27
FI83082B (fi) 1991-02-15
AU3704684A (en) 1985-07-11
PT79787B (en) 1986-12-11
NO850010L (no) 1985-07-04
HU193076B (en) 1987-08-28
IT8449383A1 (it) 1986-07-01
CH666274A5 (de) 1988-07-15
JPS60172989A (ja) 1985-09-06
KR920001770B1 (ko) 1992-03-02
SE8500011D0 (sv) 1985-01-02
ZA8545B (en) 1986-09-24
GR850007B (sv) 1985-05-03
CA1265512A (en) 1990-02-06
IL73989A (en) 1988-10-31
SG81390G (en) 1990-11-23
GB2152504A (en) 1985-08-07
GB2152504B (en) 1987-10-07
GB8500091D0 (en) 1985-02-13
SE466451B (sv) 1992-02-17
FI850012A0 (fi) 1985-01-02
HK105890A (en) 1990-12-21
FI850012L (fi) 1985-07-04
ES552577A0 (es) 1987-05-16
HUT37800A (en) 1986-02-28
DE3500090C2 (sv) 1993-09-23
IL73989A0 (en) 1985-04-30
GB8400024D0 (en) 1984-02-08
DK1585A (da) 1985-07-04
PH22630A (en) 1988-10-28
DE3500090A1 (de) 1985-07-11
NL8403974A (nl) 1985-08-01
FR2557571B1 (fr) 1987-04-17
NO165400B (no) 1990-10-29
KR850005446A (ko) 1985-08-26
AU578441B2 (en) 1988-10-27
DK1585D0 (da) 1985-01-02
NZ210725A (en) 1988-02-12
SE8500011L (sv) 1985-07-04
ATA1285A (de) 1990-08-15
AT392279B (de) 1991-02-25
IT1178349B (it) 1987-09-09
JPH0791305B2 (ja) 1995-10-04
FR2557571A1 (fr) 1985-07-05
ES8703884A1 (es) 1987-03-01
LU85719A1 (fr) 1985-10-22
ES539311A0 (es) 1987-03-01
IT8449383A0 (it) 1984-12-31
US4602012A (en) 1986-07-22
BE901436A (fr) 1985-07-03
PT79787A (en) 1985-02-01

Similar Documents

Publication Publication Date Title
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO158021C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt d-fenylalanyl-l-prolyl-l-argininaldehydsulfat.
NO159089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.
NO161065C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-azetidinoner.
NO871267D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
NO164097C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater.
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO162858C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive thiazolidinderivater.
NO166083C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater.
NO164168C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,7,4-triazolforbindelser.
NO167912C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aromatiske forbindelser
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO166326C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater.
NO159528C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater.
NO165842C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO167570C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive flavonforbindelser.
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO164020C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.
NO161177C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive tioetere.
NO160000C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser.
NO163330C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater.